Department of Medicine
-
April 28, 2022
Studies combine genetic testing, electronic health records to find undiagnosed diseases
Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations. -
April 25, 2022
Molecular testing across tumor types
The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets. -
April 21, 2022
VUMC a national leader in physician-scientist training
Physician-scientists from Vanderbilt University Medical Center were well represented at the recent annual meeting of the American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP) and the American Physician-Scientist Association. -
April 21, 2022
Drake, Freedman, Peebles elected AAP members
Vanderbilt's Wonder Drake, MD, Jane Freedman, MD, and Stokes Peebles, MD, have been elected to membership in the Association of American Physicians (AAP), one of the nation’s most respected medical honor societies. -
April 21, 2022
Biltibo receives career development award to support hematology research
Vanderbilt's Eden Biltibo, MD, a clinical fellow in the Division of Hematology and Oncology, has been selected for the 2022 ASH-CIBMTR-ASTCT Career Development Award. -
April 15, 2022
Music therapy comes to Palliative Care Unit
“Music opens many new perspectives and pathways that patients otherwise would not have." -
April 14, 2022
VUMC research team receives $1 million grant from AHA to study impact of long-COVID on heart
A research team led by Cyndya Shibao, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center (VUMC), has received a three-year, $1-million grant from the American Heart Association to study long-term effects of COVID-19 on the heart and cardiovascular system.